Answers are grounded in this paper and cite their sources.
The present study investigates the effect of compounds that are known to elevate cAMP on the phospholipid metabolism of platelets. Prostaglandin E1, forskolin and isobutylmethylxanthine induce an increase in [32P]-phosphatidylinositol 4-phosphate (PIP) in platelets prelabelled with [32P]orthophosphate. Possible roles of this phenomenon are discussed in view of the inhibitory effect of cAMP elevation on platelet activation.
No takes yet. Share an insight, caveat, or question.
Courcelles et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: